Market Report

African Health Insurance and Financing 2026: Reliance Health, Turaco, and the Out-of-Pocket Payment Problem

ABA Editorial · Oct 4, 2025 · 13 min read

African health financing is dominated by out-of-pocket payments that expose households to catastrophic expenses when illness strikes. Health insurance coverage is low across most of the continent. Insurance-technology hybrids including Reliance Health in Nigeria and Turaco in East Africa have attempted to address the payer problem by spreading risk across larger groups. This report maps the health financing landscape.

African health financing is dominated by out-of-pocket payments. The majority of African patients pay for healthcare at the point of service from household cash rather than through insurance, pre-paid health plans, or tax-funded public health systems. The consequences are predictable and severe. Households facing unexpected medical costs often must choose between medical care and basic needs including food and school fees. Catastrophic medical expenses drive families into poverty. Preventive care is neglected because the household cannot afford to spend money on health until illness becomes acute. And the fragmented payment system undermines any efforts to build coordinated care networks, because providers cannot predict which patients can actually pay for recommended treatments. This report maps the African health financing landscape, the operators attempting to improve it, and the structural conditions that make the payer problem one of the most difficult components of African healthcare to address.

The public health system layer

Most African countries operate public health systems funded through general government revenue, supplemented by donor financing for specific disease programs. The quality and reach of these public systems varies dramatically. Some, including Rwanda's community-based health insurance system and South Africa's public hospital network, provide meaningful coverage to large shares of their populations. Others provide limited services that leave most patients dependent on out-of-pocket payment for anything beyond the most basic care. The trajectory of public health financing depends on broader fiscal conditions that most ministries of health cannot control independently.

Reliance Health and the Nigerian insurance-technology model

Reliance Health, founded in Nigeria and a Y Combinator participant, built one of the most visible African insurance-technology hybrids. The company offers health insurance plans to Nigerian individuals and employer groups, with telemedicine consultation, pharmacy delivery, and other services bundled into the insurance product. The bundling approach addresses a specific structural problem: individual Nigerians are often reluctant or unable to pay separately for each healthcare service they need, but they may be willing to pay a monthly insurance premium that covers multiple services as a package.

Reliance Health has faced the same operational pressures as the broader African healthtech sector. Through 2025, the company reportedly laid off more than 100 employees as it pursued break-even operations. The restructuring does not invalidate the insurance-technology model; it reflects the difficulty of achieving sustainable unit economics in a market where many potential customers cannot afford premium insurance products and where claim costs can scale faster than revenue during adverse health events.

Turaco and the East African microinsurance model

Turaco has built a different insurance-technology model focused on microinsurance for low-income customers in East Africa. The company offers low-cost insurance products that cover specific health events, with distribution partnerships that allow premiums to be deducted from other financial transactions (mobile money accounts, savings deposits, employer payroll systems). The microinsurance approach targets customers who cannot afford comprehensive insurance coverage but can afford small premiums for specific protections.

By late 2025, Turaco had reached over 1 million customers across Kenya and other East African markets. The company's distribution model partners with fintechs, employers, and financial service providers to reach customers who would be uneconomic to acquire through direct marketing. This distribution approach is similar to the B2B insurance distribution that Pula Advisors has built in agricultural insurance, and it suggests that partnership-based distribution is one of the most viable paths to scale for African insurance operators of any type.

The CarePay and digital payment infrastructure

CarePay, operating across multiple African markets, provides payment infrastructure that connects health insurers, healthcare providers, and patients. The platform handles claims processing, payment verification, and provider reimbursement for insurance products offered by multiple carriers. CarePay's role is infrastructural rather than consumer-facing; the company does not sell insurance directly but provides the systems that allow insurance operations to function efficiently. This positioning has made CarePay a critical component of health insurance ecosystems in countries where it operates, and it illustrates the importance of payment infrastructure for insurance viability.

The informal sector coverage gap

One of the most difficult structural challenges in African health insurance is covering the informal sector. The majority of workers in most African countries operate outside formal employment, meaning that they cannot be reached through employer-based insurance schemes that work in countries with mature formal labor markets. Reaching these workers requires either individual marketing (which is expensive and produces high churn) or government-subsidized community insurance schemes (which require fiscal capacity that most African governments struggle to mobilize).

Rwanda's community-based health insurance scheme is one of the most successful African examples of reaching informal sector workers, with coverage rates that substantially exceed most peer countries. The model depends on community-level organization, premium subsidies for the poorest households, and strong government commitment. Replicating this model in larger countries with less institutional capacity has been difficult, and most attempts have produced more modest results.

The donor-financed parallel systems

International donors including the Global Fund, Gavi, PEPFAR, and others finance significant portions of healthcare delivery for specific disease categories (HIV, tuberculosis, malaria, vaccines, reproductive health) across many African countries. These donor-financed programs effectively function as parallel health financing systems, providing services to patients free of charge at the point of service while the donors cover the cost to providers. The result is a fragmented financing environment where a given patient might access some services through donor-financed programs, other services through fragile public systems, and still others through out-of-pocket payment at private providers.

The donor-financed systems have delivered significant health gains in the categories they cover, but they create sustainability questions when donor priorities shift or funding contracts. African countries relying heavily on donor financing for specific disease categories remain vulnerable to decisions made in distant capitals about funding levels and strategic priorities.

What to watch in 2026

Three indicators will shape African health financing. First, whether Reliance Health and Turaco demonstrate sustainable unit economics that would validate the insurance-technology approach for replication in additional markets. Second, whether additional African countries develop successful community-based insurance schemes following the Rwandan model. Third, whether donor financing commitments remain stable or whether shifts in international priorities reduce the parallel systems that currently deliver significant portions of African health services. Health financing is the slowest-moving component of African healthcare to transform, but it is also the most fundamental constraint on what any other intervention can achieve.